May 2018 – M4K Pharma

Reaction Biology Joins the Fight Against DIPG with M4K Pharma [News Release]

By Arij| 2018-05-24T14:37:37+00:00 May 24th, 2018|

Reaction Biology Joins the Fight Against DIPG with M4K Pharma [News Release] Malvern, PA- May 23, 2018. Reaction Biology Corporation (“RBC”), a leading contract research organization providing early stage drug discovery services, announced that it has partnered with M4K Pharma (“M4K”), an open science drug discovery and development company, in the fight against diffuse [...]

Recording of M4K Pharma’s Open Scientific Update Meeting May 2018

By Arij| 2018-05-09T14:55:42+00:00 May 9th, 2018|

M4K Pharma Open Scientific Update Meeting May 2018- Recording Full recording from M4K Pharma's Scientific Update Meeting - May 9th, 2018. Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. Everyone is invited to dial-in and join [...]